Prevalence of Functional Dyspepsia in a Rural Community of Bangladesh : A Cross Sectional Study
2026年7月5日 更新者:Jabadur Rahman Peom、Bangladesh Medical University
Prevalence of Functional Dyspepsia in Rural Community of Bangladesh: A Cross Sectional Study
Functional dyspepsia (FD) is a common gastrointestinal disorder with an important impact on quality of life.
There is a paucity of updated data on the prevalence of FD in rural areas of Bangladesh.
The present study will be carried out to find the prevalence of FD in a community in rural Bangladesh.
It also assesses potential risk factors.
Eligible participants will first be evaluated for symptoms by a clinical interview using the standardized Rome IV functional dyspepsia questionnaire.
Those who meet Rome IV criteria will then have an upper gastrointestinal endoscopy to exclude underlying organic diseases to establish a definitive diagnosis.
Eventually patients with normal endoscopic findings will be diagnosed as having functional dyspepsia.
This allows the accurate calculation of disease prevalence.
Researchers will gather demographic information, lifestyle habits, and dietary patterns.
The results will give important baseline data on rural FD burdens.
Such data can inform community health care interventions.
研究概览
地位
招聘中
条件
研究类型
观察性的
注册 (估计的)
730
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Jabadur Rahman Peom
- 电话号码:+8801925311811
- 邮箱:peom1994@gmail.com
研究联系人备份
- 姓名:Samia Khanam Yeana
- 电话号码:+880 1671122573
- 邮箱:khansamiayeana@gmail.com
学习地点
-
-
-
Dhaka、孟加拉国
- 招聘中
- Bangladesh Medical University, Dhaka
-
接触:
- Mohammad Asadur Rahman, MD
- 电话号码:+8801914239923
- 邮箱:dr.asad74@gmail.com
-
接触:
- Dewan Saifuddin Ahmed, FCPS, MD
- 电话号码:+8801711533495
- 邮箱:saifgastro@gmail.com
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
是的
取样方法
概率样本
研究人群
Place of study: Shimulia Union, Ashulia, Savar, Dhaka, Bangladesh.
Study Population: All adults of two villages of Shimulia Union who will give their consent to participate in the study.
描述
Inclusion Criteria:
- Age 18 years or above
- Resident of the selected community
Exclusion Criteria:
- Known diagnosis of organic GI diseases.(e.g., Peptic ulcer disease, Inflammatory Bowel Disease, celiac disease, Malignancy, Intestinal Tuberculosis)
- Severe cognitive impairment, or critical illness
- Individuals with a history of major abdominal surgery
- Pregnant women
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Prevalence of Functional Dyspepsia in a Rural Community of Bangladesh
大体时间:From January 2026 to December 2026
|
From January 2026 to December 2026
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 研究主任:Mohammad Asadur Rahman、Bangladesh Medical University
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Kim YS, Kim N. Functional Dyspepsia: A Narrative Review With a Focus on Sex-Gender Differences. J Neurogastroenterol Motil. 2020 Jul 30;26(3):322-334. doi: 10.5056/jnm20026.
- Yamamoto Y, Furukawa S, Watanabe J, Kato A, Kusumoto K, Takeshita E, Ikeda Y, Yamamoto N, Kohara K, Saeki Y, Hiasa Y. Association Between Body Mass Index and Functional Dyspepsia in Young Japanese People. J Neurogastroenterol Motil. 2022 Apr 30;28(2):276-282. doi: 10.5056/jnm21076.
- Rahman MM, Ghoshal UC, Kibria MG, Sultana N, Yusuf MA, Nahar S, Ahmed F, Rowshon A, Hasan M. Functional Dyspepsia, Peptic Ulcer, and Helicobacter pylori Infection in a Rural Community of South Asia: An Endoscopy-Assisted Household Survey. Clin Transl Gastroenterol. 2021 Apr 16;12(4):e00334. doi: 10.14309/ctg.0000000000000334.
- Perveen I, Rahman MM, Saha M, Rahman MM, Hasan MQ. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh. Indian J Gastroenterol. 2014 May;33(3):265-73. doi: 10.1007/s12664-014-0447-1. Epub 2014 Mar 26.
- Mounsey A, Barzin A, Rietz A. Functional Dyspepsia: Evaluation and Management. Am Fam Physician. 2020 Jan 15;101(2):84-88.
- Miwa H, Nagahara A, Asakawa A, Arai M, Oshima T, Kasugai K, Kamada K, Suzuki H, Tanaka F, Tominaga K, Futagami S, Hojo M, Mihara H, Higuchi K, Kusano M, Arisawa T, Kato M, Joh T, Mochida S, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for functional dyspepsia 2021. J Gastroenterol. 2022 Feb;57(2):47-61. doi: 10.1007/s00535-021-01843-7. Epub 2022 Jan 21.
- Kovacs DB, Szekely A, Hubai AG, Palsson O. Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar. BMJ Open Gastroenterol. 2022 Aug;9(1):e000979. doi: 10.1136/bmjgast-2022-000979.
- Harer KN, Hasler WL. Functional Dyspepsia: A Review of the Symptoms, Evaluation, and Treatment Options. Gastroenterol Hepatol (N Y). 2020 Feb;16(2):66-74.
- Esterita T, Dewi S, Suryatenggara FG, Glenardi G. Association of Functional Dyspepsia with Depression and Anxiety: A Systematic Review. J Gastrointestin Liver Dis. 2021 Jun 18;30(2):259-266. doi: 10.15403/jgld-3325.
- Abdelazim O, Hassnine AA, Fathy B, Mgdy A, Semeda N, Mahmoud SR, Saad ZM, Mahmoud HA. The prevalence of functional dyspepsia using Rome IV questionnaire among chronic kidney disease patients. Ren Fail. 2024 Dec;46(1):2344651. doi: 10.1080/0886022X.2024.2344651. Epub 2024 Apr 24.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年1月10日
初级完成 (估计的)
2026年12月1日
研究完成 (估计的)
2026年12月1日
研究注册日期
首次提交
2026年7月5日
首先提交符合 QC 标准的
2026年7月5日
首次发布 (实际的)
2026年7月10日
研究记录更新
最后更新发布 (实际的)
2026年7月10日
上次提交的符合 QC 标准的更新
2026年7月5日
最后验证
2026年7月1日
更多信息
与本研究相关的术语
其他研究编号
- 5877
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
未定
IPD 计划说明
Because the study data includes sensitive personal health and clinical information for which participants did not grant broader sharing consent, individual-level data will not be publicly available.
To safeguard participant privacy and confidentiality, access to individual data is strictly confined to the primary study investigators.
Dissemination of findings through publications and presentations will rely solely on aggregate, unidentified data.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.